ClinicalTrials.Veeva

Menu

Cerebral Near Infrared Spectroscopy in Out-of-Hospital Cardiac Arrest and Neurological Prognosis (NISOHCA)

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

Out-of-hospital Cardiac Arrest (OHCA)

Treatments

Other: Cerebral Near infrared spectroscopy (NIRSc).

Study type

Interventional

Funder types

Other

Identifiers

NCT06972329
2022PI126
2025-A00903-46 (Other Identifier)

Details and patient eligibility

About

Out-of-hospital cardiac arrest (OHCA) prognosis remains poor : 7% of patients surviving without neurological impairment.

65% of patients dying after hospital admission were neurologically impaired. When treating a patient with CA, neurological outcome remains extremely difficult to predict, especially in the pre-hospital setting. Practitioners have very little objective information to help them with neuropronostication.

Although an EtCO2 level of < 10 mmHg is associated with a poor neurological prognosis, European recommendations point out that this data alone is not currently sufficient to predict a patient's prognosis or to make a decision to stop resuscitation. Current recommendations do not suggest any other objective parameter during resuscitation for neuropronostication of patients with out-of-hospital cardiac arrest.

Cerebral tissue oxygen saturation (rSO2) is measured using the near infrared spectrometry (NIRS) technique. Cerebral NIRS (cNIRS) enables non-invasive measurement of changes in cerebral oximetry during the management of a cardiac arrest (CA).

Various clinical studies conducted over the last ten years have demonstrated that there is a probable link between cNIRS levels during resuscitation and return of spontaneous circulation (ROSC), but a clear threshold value has not been defined.

The aim of the NISOHCA study is to confirm that a 40% threshold of cNIRS in the pre-hospital setting for OHCA can specifically predict survival with good neurological outcome at D90 .

Enrollment

542 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years.
  • Non-traumatic out-of-hospital cardiac arrest witnessed and managed by the mobile emergency unit (SMUR).

Exclusion criteria

  • Scalp/cranial or facial injury preventing the placement of electrodes for NIRS measurement.
  • Spontaneous cardiac activity upon the arrival of the SMUR.
  • Decision by the SMUR physician not to initiate specialized resuscitation.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

542 participants in 1 patient group

Cerebral Near infrared spectroscopy (NIRSc) group
Experimental group
Description:
The use of cerebral Near infrared spectroscopy to predict the neurological prognosis of patients treated for out-of-hospital cardiac arrest.
Treatment:
Other: Cerebral Near infrared spectroscopy (NIRSc).

Trial contacts and locations

6

Loading...

Central trial contact

Deborah JAEGER, MD; Tahar CHOUIHED, MD PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems